Published in Infect Immun on May 01, 1977
Bacterial toxins: a table of lethal amounts. Microbiol Rev (1982) 3.74
Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect Immun (1998) 2.44
Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C. Infect Immun (1982) 2.43
Mechanism of action of the group A streptococcal C5a inactivator. Proc Natl Acad Sci U S A (1985) 2.38
Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins. Infect Immun (1978) 2.35
Heterogeneity of group A streptococcal pyrogenic exotoxin type B. Infect Immun (1978) 2.26
Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Microbiol (1991) 2.07
Group A streptococcal pyrogenic exotoxin: pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock. Infect Immun (1978) 1.96
Purification and physicochemical and biological characterization of a staphylococcal pyrogenic exotoxin. Infect Immun (1979) 1.88
Effect of glycerol monolaurate on bacterial growth and toxin production. Antimicrob Agents Chemother (1992) 1.87
Suppression of antibody response by group A streptococcal pyrogenic exotoxin and characterization of the cells involved. Infect Immun (1978) 1.58
Nonspecific T-lymphocyte mitogenesis by pyrogenic exotoxins from group A streptococci and Staphylococcus aureus. Infect Immun (1979) 1.51
Bacteriophage involvement in group A streptococcal pyrogenic exotoxin A production. J Bacteriol (1986) 1.49
Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev (2013) 1.48
Quantification and toxicity of group A streptococcal pyrogenic exotoxins in an animal model of toxic shock syndrome-like illness. J Clin Microbiol (1989) 1.43
Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins. Infect Immun (1991) 1.43
Reinterpretation of the Dick test: role of group A streptococcal pyrogenic exotoxin. Infect Immun (1979) 1.41
Alteration of clearance function by group A streptococcal pyrogenic exotoxin and its relation to suppression of the antibody response. Infect Immun (1978) 1.40
Bacteriophage association of streptococcal pyrogenic exotoxin type C. J Bacteriol (1989) 1.40
Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein. Infect Immun (1992) 1.37
Glycerol monolaurate inhibits the effects of Gram-positive select agents on eukaryotic cells. Biochemistry (2006) 1.33
Purification and properties of an extracellular blastogen produced by group A streptococci. J Exp Med (1979) 1.25
Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B. Infect Immun (1994) 1.21
Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1. Infect Immun (1994) 1.20
Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes. Infect Immun (1997) 1.16
Enzyme-linked immunosorbent assay for detection of type A streptococcal exotoxin: kinetics and regulation during growth of Streptococcus pyogenes. Infect Immun (1981) 1.15
Biological and immunological properties of the carboxyl terminus of staphylococcal enterotoxin C1. Infect Immun (1989) 1.14
Transfer of group A streptococcal pyrogenic exotoxin production to nontoxigenic strains of lysogenic conversion. Infect Immun (1980) 1.14
Expression of staphylococcal enterotoxin C1 in Escherichia coli. Infect Immun (1987) 1.13
Inhibition of ribonucleic acid synthesis by group A streptococcal pyrogenic exotoxin. Infect Immun (1980) 1.09
Cross-neutralization of staphylococcal and streptococcal pyrogenic toxins by monoclonal and polyclonal antibodies. Infect Immun (1988) 1.06
Activation of murine T-suppressor lymphocytes by group A streptococcal and staphylococcal pyurogenic exotoxins. Infect Immun (1980) 1.03
Cell and receptor requirements for streptococcal pyrogenic exotoxin T-cell mitogenicity. Infect Immun (1991) 0.98
Mechanism of stimulation of T cells by Streptococcus pyogenes: isolation of a major mitogenic factor, cytoplasmic membrane-associated protein. Infect Immun (1992) 0.89
Streptococcus agalactiae toxic shock-like syndrome: two case reports and review of the literature. Medicine (Baltimore) (2013) 0.84
Residues 20, 22, and 26 determine the subtype specificities of staphylococcal enterotoxins C1 and C2. Infect Immun (1992) 0.84
Detection and nucleotide sequence analysis of the speC gene in Swedish clinical group A streptococcal isolates. J Clin Microbiol (1994) 0.83
Ganglioside and monosaccharide inhibition of nonspecific lymphocyte mitogenicity by group A streptococcal pyrogenic exotoxins. Infect Immun (1980) 0.82
Significance of endotoxin in lethal synergy between bacteria associated with sudden infant death syndrome: follow up study. J Clin Pathol (1996) 0.78
Effects of carrier ampholyte contamination on the biological and biochemical properties of streptococcal pyrogenic exotoxin type C. Infect Immun (1983) 0.78
Natural phosphorylation of group A streptococcal pyrogenic exotoxin type C. Infect Immun (1979) 0.75
The gene encoding a new mitogenic factor in a Streptococcus pyogenes strain is distributed only in group A streptococci. Infect Immun (1994) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem (1969) 142.11
Spectroscopic determination of tryptophan and tyrosine in proteins. Biochemistry (1967) 21.79
A purified group A streptococcal pyrogenic exotoxin. Physiochemical and biological properties including the enhancement of susceptibility to endotoxin lethal shock. J Exp Med (1970) 3.76
Host-parasite factors in group A streptococcal infections. Pyrogenic and other effects of immunologic distinct exotoxins related to scarlet fever toxins. J Exp Med (1960) 3.35
Host-parasite relationships among group A streptococci. IV. Suppression of antibody response by streptococcal pyrogenic exotoxin. J Bacteriol (1968) 2.16
Further purification of group A streptococcal pyrogenic exotoxin and characterization of the purified toxin. Infect Immun (1976) 2.08
HOST-PARASITE RELATIONSHIPS AMONG GROUP A STREPTOCOCCI. 3. DEPRESSION OF RETICULOENDOTHELIAL FUNCTION BY STREPTOCOCCAL PYROGENIC EXOTOXINS. J Bacteriol (1965) 1.98
Enhanced immune response after immunosuppression by Streptococcal pyrogenic exotoxin. Infect Immun (1973) 1.92
Deregulation of mouse antibody-forming cells in vivo in cell culture by streptococcal pyrogenic exotoxin. Infect Immun (1975) 1.60
Studies on adenosine triphosphate transphosphorylases. I. Amino acid composition of adenosine triphosphate-adenosine 5'-phosphate transphosphorylase (myokinase). J Biol Chem (1962) 1.42
The pyrogenic effect of scarlet fever toxin. IV. Pyrogenicity of strain C 203 U filtrate: comparison with some basic characteristics of the known types of scarlet fever toxin. Yale J Biol Med (1970) 1.06
THE PYROGENIC EFFECT OF SCARLET FEVER TOXIN. I. NEUTRALIZATION WITH ANTITOXIN; THE NATURE OF TOLERANCE. Folia Microbiol (Praha) (1965) 1.05
The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature (1983) 19.44
Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis (1981) 8.40
Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med (1989) 8.01
Exotoxins of Staphylococcus aureus. Clin Microbiol Rev (2000) 7.35
Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature (1996) 7.11
Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci U S A (1991) 5.46
Puffing frequency and nicotine intake in cigarette smokers. Br Med J (1970) 4.69
Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol (2001) 4.48
Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med (1987) 4.38
Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet (1993) 4.06
Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol (1990) 3.89
A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proc Natl Acad Sci U S A (1990) 3.76
A purified group A streptococcal pyrogenic exotoxin. Physiochemical and biological properties including the enhancement of susceptibility to endotoxin lethal shock. J Exp Med (1970) 3.76
COMPLEMENT FIXATION WITH THE NEUROTROPIC VIRUSES. J Exp Med (1943) 3.65
Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet (1992) 3.46
Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2003) 3.33
Biological activities of lipid A complexed with bovine-serum albumin. Eur J Biochem (1972) 3.04
Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J Infect Dis (1983) 3.00
Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems. J Clin Microbiol (1993) 2.94
Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin). J Infect Dis (1993) 2.84
Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect Immun (1989) 2.77
Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet (1986) 2.69
The nucleotide and partial amino acid sequence of toxic shock syndrome toxin-1. J Biol Chem (1986) 2.63
An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA (1997) 2.52
Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene and relationship between the toxin and the streptococcal proteinase precursor. J Bacteriol (1990) 2.50
Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Intern Med (1994) 2.44
Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C. Infect Immun (1982) 2.43
Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins. Infect Immun (1978) 2.35
Identification of a novel two-component regulatory system that acts in global regulation of virulence factors of Staphylococcus aureus. J Bacteriol (2001) 2.33
Ontogeny of the immune response. I. Development of immunoglobulins in germfree and conventional colostrum-deprived piglets. J Immunol (1966) 2.28
Outbreak of group A streptococcus septicemia in children. Clinical, epidemiologic, and microbiological correlates. JAMA (1991) 2.27
Heterogeneity of group A streptococcal pyrogenic exotoxin type B. Infect Immun (1978) 2.26
Comparison of restriction endonuclease analysis, ribotyping, and pulsed-field gel electrophoresis for molecular differentiation of Clostridium difficile strains. J Clin Microbiol (1994) 2.23
Nucleotide sequence of the staphylococcal enterotoxin C1 gene and relatedness to other pyrogenic toxins. Mol Gen Genet (1987) 2.21
Group A streptococcal phage T12 carries the structural gene for pyrogenic exotoxin type A. Mol Gen Genet (1984) 2.19
Host-parasite relationships among group A streptococci. IV. Suppression of antibody response by streptococcal pyrogenic exotoxin. J Bacteriol (1968) 2.16
Recurrent toxin-mediated perineal erythema. Arch Dermatol (1996) 2.09
Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources. Infect Immun (1983) 2.08
Further purification of group A streptococcal pyrogenic exotoxin and characterization of the purified toxin. Infect Immun (1976) 2.08
Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis (1993) 2.07
Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Microbiol (1991) 2.07
Role of antibodies in reactions to gram-negative bacterial endotoxins. Ann N Y Acad Sci (1966) 2.02
Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial. Ann Intern Med (1992) 2.00
Crystal structure of the superantigen staphylococcal enterotoxin type A. EMBO J (1995) 1.99
Group A streptococcal pyrogenic exotoxin: pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock. Infect Immun (1978) 1.96
Enhanced immune response after immunosuppression by Streptococcal pyrogenic exotoxin. Infect Immun (1973) 1.92
Biologically active endotoxins from Salmonella mutants deficient in O- and R-polysaccharides and heptose. J Bacteriol (1967) 1.92
Effect of lymphocytes from patients with ulcerative colitis on human adult colon epithelial cells. Gastroenterology (1966) 1.91
Purification and physicochemical and biological characterization of a staphylococcal pyrogenic exotoxin. Infect Immun (1979) 1.88
Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project. J Infect Dis (1995) 1.88
Biochemical and biological properties of Staphylococcal enterotoxin K. Infect Immun (2001) 1.80
Acute group G streptococcal myositis associated with streptococcal toxic shock syndrome: case report and review. Clin Infect Dis (1996) 1.80
Preparation of toxic shock syndrome toxin-1. Methods Enzymol (1988) 1.78
Clindamycin-induced suppression of toxic-shock syndrome--associated exotoxin production. J Infect Dis (1984) 1.78
Production of pyrogenic exotoxin by groups of streptococci: association with group A. J Infect Dis (1979) 1.77
Nonpurulent response to toxic shock syndrome toxin 1-producing Staphylococcus aureus. Relationship to toxin-stimulated production of tumor necrosis factor. J Immunol (1988) 1.77
Streptococcal pyrogenic exotoxin type A (scarlet fever toxin) is related to Staphylococcus aureus enterotoxin B. Mol Gen Genet (1986) 1.74
Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome. Ann Intern Med (1982) 1.73
Toxic shock syndrome. A newly recognized complication of influenza and influenzalike illness. JAMA (1987) 1.69
Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B. Immunity (1998) 1.68
Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes. J Exp Med (1991) 1.66
Toxic-shock-syndrome toxin 1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes. J Infect Dis (1985) 1.65
Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med (1995) 1.65
Suppression of antibody response by group A streptococcal pyrogenic exotoxin and characterization of the cells involved. Infect Immun (1978) 1.58
Group A streptococcal peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis. Am J Med (1989) 1.57
Reporting of toxic shock syndrome Staphylococcus aureus in 1982 to 1990. J Infect Dis (1991) 1.57
Nucleotide sequence of streptococcal pyrogenic exotoxin type C. Infect Immun (1988) 1.56
Ontogeny of the immune response. II. Characterization of 19S-gamma-G- and 7S-gamma-G-immunoglobulins in the true primary and secondary responses in piglets. J Immunol (1966) 1.54
Molecular characterization of a novel Staphylococcus aureus serine protease operon. Infect Immun (2001) 1.52
Nonspecific T-lymphocyte mitogenesis by pyrogenic exotoxins from group A streptococci and Staphylococcus aureus. Infect Immun (1979) 1.51
Glycerol monolaurate inhibits the production of beta-lactamase, toxic shock toxin-1, and other staphylococcal exoproteins by interfering with signal transduction. J Bacteriol (1994) 1.50
Bacteriophage involvement in group A streptococcal pyrogenic exotoxin A production. J Bacteriol (1986) 1.49
Oxygen and carbon dioxide regulation of toxic shock syndrome toxin 1 production by Staphylococcus aureus MN8. J Clin Microbiol (2000) 1.49
Alteration of immune function by staphylococcal pyrogenic exotoxin type C: possible role in toxic-shock syndrome. J Infect Dis (1983) 1.48
Streptococcus pyogenes pharyngitis: characterization of strains by multilocus enzyme genotype, M and T protein serotype, and pyrogenic exotoxin gene probing. J Clin Microbiol (1992) 1.47
Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease. Pediatr Res (1997) 1.47
Staphylococcus aureus associated with toxic shock syndrome: phage typing and toxin capability testing. Ann Intern Med (1982) 1.45
Immunochemical assays for toxic shock syndrome toxin-1. Methods Enzymol (1988) 1.44
Structure of toxic shock syndrome toxin 1. Biochemistry (1993) 1.43
Quantification and toxicity of group A streptococcal pyrogenic exotoxins in an animal model of toxic shock syndrome-like illness. J Clin Microbiol (1989) 1.43
Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins. Infect Immun (1991) 1.43
Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II. Immunity (2001) 1.42
Reinterpretation of the Dick test: role of group A streptococcal pyrogenic exotoxin. Infect Immun (1979) 1.41
Analysis of toxic shock syndrome isolates producing staphylococcal enterotoxins B and C1 with use of southern hybridization and immunologic assays. Rev Infect Dis (1989) 1.40
Alteration of clearance function by group A streptococcal pyrogenic exotoxin and its relation to suppression of the antibody response. Infect Immun (1978) 1.40
Bacteriophage association of streptococcal pyrogenic exotoxin type C. J Bacteriol (1989) 1.40
A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor beta chain and major histocompatibility complex class II. J Exp Med (1998) 1.39
Pyrogenicity and immunogenicity of lipid A complexed with bovine serum albumin or human serum albumin. Infect Immun (1973) 1.38
Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein. Infect Immun (1992) 1.37
Nucleotide sequences and biologic properties of toxic shock syndrome toxin 1 from ovine- and bovine-associated Staphylococcus aureus. J Infect Dis (1992) 1.34
Toxic shock syndrome Staphylococcus aureus: effect of tampons on toxic shock syndrome toxin 1 production. Obstet Gynecol (1984) 1.33